Part D drug consolidation could save Medicare $150 million, CMS finds

Share this article:

Consolidating drugs covered by Medicare Part B and Part D under Part D could save Medicare nearly $150 million, according to a new report from the Centers for Medicare & Medicaid Services.

By contrast, the report found that consolidating drugs under Medicare Part B could increase Medicare spending by $52 million. 

Though the vast majority of drugs for seniors are covered under the Medicare Part D program, there are still some drugs covered through Part B. These drugs include injectable insulin, certain vaccines—including for influenza—and drugs dispensed by nebulizer.

While the consolidation under Medicare Part D could save the program money, it would adversely impact Medicare beneficiaries in the pocketbook, the report found. Because Part D has “less generous coverage rules,” switching the coverage of drugs from Part B to Part D would cost beneficiaries roughly $267 in added out-of-pocket expenses. 

Share this article:

More in News

Profile: AHCA's money player

Profile: AHCA's money player

If there's a prevailing theme around the hours American Health Care Association senior fellow Elise Smith keeps, it's that they are constant.

Residents cheer tractor parade

Residents cheer tractor parade

Many residents of the Oskaloosa Care Center in southern Iowa used to be farmers. They're reminded of their past by the cornfield next to the nursing home — and, once ...

No need for injury

No need for injury

Due to dynamic factors in moving residents, facilities must invest wisely in lifts, slings and batteries to make sure workers stay safe while performing transfers